Tel: +86 (0)571 8102-5280
Email: sales@molcore.com
Language :
English
中文版
日本語
Search
Home
About Us
Services
Custom Synthesis
Process development
IP & Quality
CRO&CDMO
Facility
R&D Center
Manufacturing
Products
Contact Us
Cas Index 1
Home
Sitemap
Cas Index 1
Recently searched keywords
1052559-55-3
,
2250243-47-9
,
80625-14-5
,
477871-28-6
,
5688-82-4
,
618092-26-5
,
164982-33-6
,
1361889-43-1
,
2013582-86-8
,
1021089-12-2
,
2097974-60-0
,
2166459-48-7
,
1010189-79-3
,
1255637-76-3
,
1620330-72-4
,
2089649-07-8
,
56066-63-8
,
676627-67-1
,
886770-31-6
,
1023540-85-3
,
1019999-18-8
,
1410737-35-7
,
1628483-64-6
,
1584229-69-5
,
1781791-76-1
,
1864057-22-6
,
1932084-31-5
,
20330-99-8
,
2168959-86-0
,
2209093-30-9
,
2306276-13-9
,
2673269-82-2
,
118720-35-7
,
732252-98-1
,
74135-04-9
,
756500-23-9
,
884507-32-8
,
90389-42-7
,
95851-90-4
,
1197160-28-3
,
1378511-58-0
,
1093413-28-5
,
1173880-09-5
,
10413-00-0
,
1226212-38-9
,
146369-21-3
,
1781707-40-1
,
1171070-31-7
,
1783927-71-8
,
791803-08-2
,
883520-71-6
,
1038246-74-0
,
1416553-63-3
,
1421687-46-8
,
1022892-14-3
,
550299-54-2
,
957948-74-2
,
112037-52-2
,
898747-80-3
,
1164548-54-2
Products Sitemap
Cas Index
1
2
3
4
5
6
7
8
9
Name Index
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Cas Index 1
Product Number
Chemical Name
Molecular Formula
MC28F244
149399-86-0 | β-Neuraminic acid, N-acetyl-, 2-propen-1-yl ester, 4,7,8,9-tetrakis(2-propen-1-yl carbonate) 2-[2-propen-1-yl N-[(2-propen-1-yloxy)carbonyl]-2′,3′-bis-O-[(2-propen-1-yloxy)carbonyl]-5′-cytidylate] (ACI)
MC28U243
166533-22-8 | β-Neuraminic acid, N-acetyl-, methyl ester, 4,7,8,9-tetraacetate 1-[(S)-2-cyanoethyl hydrogen phosphite], 5′-ester with N-acetylcytidine 2′,3′-diacetate (9CI)
MCW84242
166533-23-9 | β-Neuraminic acid, N-acetyl-, methyl ester, 4,7,8,9-tetraacetate 2-[(S)-2-cyanoethyl N-acetyl-2′,3′-di-O-acetyl-5′-cytidylate] (9CI)
MCC84241
166734-16-3 | β-Neuraminic acid, N-acetyl-, methyl ester, 4,7,8,9-tetraacetate 1-[(R)-2-cyanoethyl hydrogen phosphite], 5′-ester with N-acetylcytidine 2′,3′-diacetate (9CI)
MC284G40
166734-17-4 | β-Neuraminic acid, N-acetyl-, methyl ester, 4,7,8,9-tetraacetate 2-[(R)-2-cyanoethyl N-acetyl-2′,3′-di-O-acetyl-5′-cytidylate] (9CI)
MC2W4239
185899-87-0 | β-Neuraminic acid, N-acetyl-2-[(acetyloxy)(2′,3′-di-O-acetyl-N-benzoyl-P-methyl-5′-cytidylyl)methyl]-2-deoxy-, methyl ester, 4,7,8,9-tetraacetate (9CI)
MC28N238
185899-88-1 | β-Neuraminic acid, N-acetyl-2-deoxy-2-[(2′,3′-di-O-acetyl-N-benzoyl-P-methyl-5′-cytidylyl)methyl]-, methyl ester, 4,7,8,9-tetraacetate (9CI)
MC284Z37
194665-72-0 | β-Neuraminic acid, N-acetyl-, methyl ester, 4,7,8,9-tetraacetate 2-(2-propenyl N-acetyl-2′,3′-di-O-acetyl-5′-cytidylate) (9CI)
MC28E223
119396-87-1 | 3,4-Dimethoxy-2-methylbenzonitrile
C10H11NO2
MCP84222
120100-41-6 | Methyl 2,4-dichloro-5-fluoro-3-iodobenzoate
C8H4Cl2FIO2
MCT84216
1005496-56-9 | β-Neuraminic acid, N-acetyl-, 2→P′-ester with cytidine 5′-(trihydrogen diphosphate) (ACI)
MC284M15
1251849-06-5 | β-Neuraminic acid, N-[N-[2-[2-[4-[2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoyl]-1-piperazinyl]-2-oxoethoxy]acetyl]-N-[2-[2-[2-[[1-oxo-3-(2-pyridinyldithio)propyl]amino]ethoxy]ethoxy]ethyl]glycylglycyl]-, 2-(hydrogen 5′-cytidylate) (ACI)
MC284Y14
1332294-13-9 | β-Neuraminic acid, N-[23-(9H-fluoren-9-yl)-1,4,17,21-tetraoxo-7,10,13,19,22-pentaoxa-3,16,20-triazatricos-1-yl]-, 2-(hydrogen 5′-cytidylate) (ACI)
MCD84213
1332367-63-1 | β-Neuraminic acid, N-[N-(15-carboxy-1-oxopentadecyl)-L-γ-glutamylglycyl]-, 2-(hydrogen 5′-cytidylate) (ACI)
MC28H212
112054-79-2 | β-Neuraminic acid, N-acetyl-9-(benzoylamino)-9-deoxy-, 2-(hydrogen 5′-cytidylate) (9CI)
MC284W11
149002-88-0 | β-Neuraminic acid, N-acetyl-, methyl ester, 4,7,8,9-tetraacetate 2-(hydrogen N-acetyl-2′,3′-di-O-acetyl-5′-cytidylate) (9CI)
MC28W210
160593-08-8 | β-Neuraminic acid, N-acetyl-8-O-(N-acetyl-4,7,8,9-tetra-O-acetyl-α-neuraminosyl)-, 1-methyl ester, 4,7-diacetate 2-[(R)-2-cyanoethyl hydrogen phosphite], intramol. 1′,9-ester, 5′-ester with N-acetylcytidine 2′,3′-diacetate (9CI)
MC28S209
160593-09-9 | β-Neuraminic acid, N-acetyl-8-O-(N-acetyl-4,7,8,9-tetra-O-acetyl-α-neuraminosyl)-, 1-methyl ester, 4,7-diacetate 2-[(R)-2-cyanoethyl N-acetyl-2′,3′-di-O-acetyl-5′-cytidylate], intramol. 1′,9-ester (9CI)
MCZ84208
160706-64-9 | β-Neuraminic acid, N-acetyl-8-O-(N-acetyl-4,7,8,9-tetra-O-acetyl-α-neuraminosyl)-, 1-methyl ester, 4,7-diacetate 2-[(S)-2-cyanoethyl hydrogen phosphite], intramol. 1′,9-ester, 5′-ester with N-acetylcytidine 2′,3′-diacetate (9CI)
MC2Y4207
160706-65-0 | β-Neuraminic acid, N-acetyl-8-O-(N-acetyl-4,7,8,9-tetra-O-acetyl-α-neuraminosyl)-, 1-methyl ester, 4,7-diacetate 2-[(S)-2-cyanoethyl N-acetyl-2′,3′-di-O-acetyl-5′-cytidylate], intramol. 1′,9-ester (9CI)
MC284Y06
188786-06-3 | β-Neuraminic acid, N-acetyl-, methyl ester, 4,7,8,9-tetraacetate 2-(2-propenyl hydrogen phosphite), 5′-ester with N-acetylcytidine 2′,3′-diacetate (9CI)
MC2U4203
146369-22-4 | β-Neuraminic acid, N-acetyl-7-deoxy-, 2-(hydrogen 5′-cytidylate) (9CI)
MCM84202
183719-98-4 | β-Neuraminic acid, N-acetyl-, 2-(hydrogen 5′-uridylate) (9CI, ACI)
MC284N01
112037-51-1 | β-Neuraminic acid, N-acetyl-9-(acetylamino)-9-deoxy-, 2-(hydrogen 5′-cytidylate) (9CI)
MC2N4200
1013030-94-8 | β-Neuraminic acid, N-acetyl-7-(acetylamino)-7,9-dideoxy-, 2-(hydrogen 5′-cytidylate) (ACI)
MCG84192
11034-36-9 | β-Solamarine, N-nitroso- (8CI)
MC284A89
138023-76-4 | β-Neuraminic acid, N-acetyl-9-deoxy-9-[[[1-[(7-hydroxy-3-oxo-3H-phenoxazin-4-yl)carbonyl]-4-piperidinyl]carbonyl]amino]-, 2-(hydrogen 5′-cytidylate) (9CI)
MC284U88
138023-80-0 | β-Neuraminic acid, N-acetyl-9-deoxy-9-[[[[4-[[4-(dimethylamino)phenyl]azo]phenyl]amino]thioxomethyl]amino]-, 2-(hydrogen 5′-cytidylate) (9CI)
MC2E4187
138023-81-1 | β-Neuraminic acid, N-acetyl-9-deoxy-9-[[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]amino]-, 2-(hydrogen 5′-cytidylate) (9CI)
MC284M70
1261779-01-4 | 3-Chloro-5-methoxybenzamide
C8H8ClNO2
Prev
Next
© Copyright 2015-2025 Hangzhou MolCore BioPharmatech Co.,Ltd. All rights reserved.